From: The diagnostic value of staging laparoscopy in gallbladder cancer: a nationwide cohort study
Staging laparoscopy N = 40 | No laparoscopy N = 143 | p-value | |
---|---|---|---|
Baseline characteristicsa | |||
Age, years, median (range) | 64 (42–86) | 67 (33–89) | 0.088 |
Gender | |||
Female | 16 (40.0%) | 93 (65.0%) | 0.004 |
Male | 24 (60.0%) | 50 (34.7%) | |
Symptoms | |||
Jaundice | 17 (42.5%) | 52 (36.4%) | 0.479 |
Abdominal pain | 29 (72.5%) | 76 (53.1%) | 0.029 |
Weight loss | 11 (27.5%) | 34 (23.8%) | 0.629 |
ASA-classification | 0.576 | ||
1 | 6 (15.0%) | 30 (21.0%) | |
2 | 25 (62.5%) | 72 (50.3%) | |
3 | 8 (20.0%) | 36 (25.2%), 2 | |
4 | 1 (2.5%) | (1.4%) | |
Primary sclerosing cholangitis | 2 (5.0%) | 7 (4.9%) | 0.978 |
Characteristics on imagingb | |||
Cholecystitis | 0 (0.0%) | 10 (7.0%) | 0.085 |
Cholecystolithiasis | 8 (20.0%) | 50 (35.0%) | 0.072 |
Gallbladder polyp | 1 (2.5%) | 6 (4.2%) | 0.621 |
N1/2 stage | 9 (22.5%) | 32 (22.4%) | 0.456 |
Liver invasion | 20 (50.0%) | 45 (31.5%) | 0.030 |
Other organ invasion | 18 (45.0%) | 34 (23.8%) | 0.008 |
cT stage | 0.104 | ||
1–2 | 4 (10.0%) | 24 (16.8%) | |
3-4 | 18 (45.0%) | 41 (28.7%) | |
X | 18 (45.0%) | 78 (54.5%) |